Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.68%
623.41
+4.20
+0.68%
—619.21618.96625.80615.58——
SX6P
Utilities
SX6P
Utilities
SX6P
+1.64%
539.58
+8.72
+1.64%
—530.86530.03540.64526.25——
SX8P
Technology
SX8P
Technology
SX8P
-0.43%
926.62
-4.00
-0.43%
—930.62924.86942.94921.75——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-0.75%
452.64
-3.41
-0.75%
—456.05452.80456.62446.45——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.33%
1,087.00
-3.63
-0.33%
—1,090.631,086.801,095.221,078.00——
SXEP
Energy
SXEP
Energy
SXEP
+2.00%
546.04
+10.70
+2.00%
—535.34536.16546.06536.16——
SXFP
Financials
SXFP
Financials
SXFP
+0.91%
898.35
+8.12
+0.91%
—890.23887.34904.15883.68——
SXKP
Communications
SXKP
Communications
SXKP
+1.44%
317.27
+4.49
+1.44%
—312.78311.95319.44310.80——
SXNP
Industrials
SXNP
Industrials
SXNP
+0.12%
1,096.86
+1.26
+0.12%
—1,095.601,090.801,109.451,082.31——
SXPP
Materials
SXPP
Materials
SXPP
-0.38%
814.95
-3.12
-0.38%
—818.07813.89826.30804.46——
600535:SHA
Tasly Pharmaceutical Group Co Ltd
CNÂ¥14.37
-1.84%
(-0.27) 1D
May 18, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600535...
Open
CNÂ¥14.64
High
CNÂ¥14.70
Low
CNÂ¥14.33
Mkt. cap
21.87B
Avg. vol.
10.82M
Volume
10.46M
P/E ratio
18.49
52-wk high
CNÂ¥17.69
52-wk low
CNÂ¥13.45
EPS
CNÂ¥0.78
Shares outstanding
1.51B
No. of employees
11K
News stories
From sources across the web
Profile
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines. It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange. In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation. In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
About Tasly Pharmaceutical Group Co Ltd
CEO-
Employees10.6K
Founded1994
Headquarters-
SectorPharmaceutical industry
Websitetasly.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.23B
2.02B
1.93B
2.16B
Cost of goods sold
712.96M
684.07M
659.71M
623.69M
Cost of revenue
712.96M
684.07M
659.71M
623.69M
Research and development expenses
139.89M
210.48M
132.23M
191.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
871.89M
844.05M
787.37M
874.15M
Operating expense
1.05B
1.06B
979.15M
1.08B
Total operating expenses
1.76B
1.74B
1.64B
1.70B
Operating income
468.48M
281.20M
286.94M
462.71M
Other non operating income
5.19M
-7.57M
-6.11M
-733.75K
EBT including unusual items
496.65M
248.13M
192.46M
461.52M
EBT excluding unusual items
456.72M
280.97M
289.16M
472.69M
Income tax expense
38.97M
45.36M
123.68M
96.97M
Effective tax rate
7.85%
18.28%
64.26%
21.01%
Other operating expenses
38.74M
1.56M
53.20M
17.23M
Net income
460.39M
209.68M
120.59M
370.24M
Net profit margin
20.61%
10.37%
6.26%
17.10%
Earnings per share
-
-
-
-
Interest and investment income
-
14.77M
14.84M
14.04M
Interest expense
-17.10M
-7.28M
-5.44M
-3.33M
Net interest expenses
-17.10M
7.49M
9.39M
10.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
557.89M
380.28M
380.23M
555.99M
Gain or loss from assets sale
-5.21M
5.21M
-8.61M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer